Finished Dosage Form

Finished Dosage Form
Product Description

modified-release tablets (MUPS and matrix tablets)film coated- or dispersible tabletsprinted tabletsmodified release capsulesmicro-tablets in capsulescontrolled substances & broad-spectrum antibioticssugar coated tablets

Acino International AG

  • CH
  • 2020
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

Acino International AG

  • CH
  • 2020
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from Acino International AG (4)

  • Granulation/Pelletization

    Product Granulation/Pelletization

    wet (aqueous & organic), dry and melt granulationfluid-bed & high shear granulationdirect compressionextrusion / spheronizationpellet layering in fluid bed processcoating of pellets fluid.bed and tray dryingsieving / blending
  • Primary packaging

    Product Primary packaging

    PVC // AluPVC/PVDC // AuPVC/PE/PVDC // AluAlu // Alucontrolled substances packagingpackaging of potent OSDsbottles (glass, plastic, aluminium) with different caps (push-on, screw, snap safe, desiccant capsules)unit dose blister
  • Contract Manufacturing Services

    Product Contract Manufacturing Services


    As a Swiss pharmaceutical manufacturer, Acino can look back on to a long history in producing oral solid dosage forms for major generic companies at the highest quality possible. Having developed profound know-how within this field, Acino has a well-known track record in manufacturing complex modified...
  • Out-Licensing

    Product Out-Licensing

    Acino is a Swiss-based company that offers high quality generic products in advanced drug delivery systems. Special focus is on narcotics and extended release formulations as part of our long-term strategy to expand the product portfolio within Oncology, Urology or Pain. The products are manufactured in ou...